Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chattem Line Extensions Help Weather Unstable Market; Stock Up 30%

This article was originally published in The Tan Sheet

Executive Summary

Chattem's focus on extending its core brands and stepping up advertising over the next several months appears to have bolstered investor confidence in the stock despite the turbulent market trends following the Sept. 11 terrorist attacks.

You may also be interested in...



Chattem Eyes International Growth, Doubling Of Net Sales

Chattem's increased commitment to its international business will begin with the hiring of a new VP of international relations in the next few weeks, Chairman and CEO Zan Guerry said during the company's year-end conference call Jan. 24

Chattem Eyes International Growth, Doubling Of Net Sales

Chattem's increased commitment to its international business will begin with the hiring of a new VP of international relations in the next few weeks, Chairman and CEO Zan Guerry said during the company's year-end conference call Jan. 24

Chattem Eyes International Growth, Doubling Of Net Sales

Chattem's increased commitment to its international business will begin with the hiring of a new VP of international relations in the next few weeks, Chairman and CEO Zan Guerry said during the company's year-end conference call Jan. 24

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093105

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel